Want to join the conversation?
Drug company $EXEL announced the outcome from the first interim analysis of CELESTIAL, a phase 3 trial of cabozantinib versus placebo in patients with advanced liver cancer, HCC, who have been previously treated with sorafenib. The Independent Data Monitoring Committee determined that the study should continue without modifications per protocol.
Late realization to $T that it cannot compete in the unlimited data market with its existing plans! Its newly launched plans seem more reasonable.
Wow, the new $HPE Pro x2 612 G2. Finally, a Surface Tab you can use for business!
$GOOG’s Waymo accuses Uber of stealing its intellectual property. Startup Otto, which was recently acquired by Uber, also named in the lawsuit. Stage set for another dramatic legal battle!
We all knew $VALE CEO Murilo Ferreira was going out soon, but now I hear he has no idea who will succeed him!